Sign In
Buy ABCL
$5.72
-0.410 (-6.69%)
At Close: Jun 03, 2026
The 7 Best Penny Stocks to Buy in Q2 2024
04:30pm, Wednesday, 27'th Mar 2024
This month in March is a great time to pick up shares in these best penny stocks to buy. I chose the companies due to their strong fundamentals and potential for significant upside.
AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024
04:05pm, Tuesday, 19'th Mar 2024
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $ABCL--AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the Bloom Burton Healthcare Conference on Tuesday, Apr
AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions
09:00am, Monday, 11'th Mar 2024
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $ABCL--AbCellera (Nasdaq: ABCL) and Biogen Inc. (Nasdaq: BIIB) have entered into a strategic collaboration to discover antibodies for a novel target th
AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024
04:30pm, Tuesday, 05'th Mar 2024
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $ABCL--AbCellera (Nasdaq: ABCL) today announced that its scientists will present four posters with data from its T-cell engager programs and platform a
3 Highly Rated Biotech Stocks to Buy for 300% Gains
06:55am, Monday, 26'th Feb 2024
Investors know that the world of biotech stocks is home to a great percentage of opportunities that can triple and quadruple their capital. It's also fairly easy to identify such stocks using screener
AbCellera Announces Resignation of Board Member
04:30pm, Friday, 23'rd Feb 2024
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $ABCL--AbCellera (Nasdaq: ABCL) today announced that Peter Thiel has notified the Company of his intention to resign from the Company's Board of Direct
AbCellera to Present at Upcoming Investor Conferences in March
08:15pm, Thursday, 22'nd Feb 2024
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $ABCL--AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the following investor conferences: 44th Annual TD Cow
AbCellera Biologics Inc. (ABCL) Q4 2023 Earnings Call Transcript
11:45pm, Tuesday, 20'th Feb 2024
AbCellera Biologics Inc. (ABCL) Q4 2023 Earnings Call Transcript
AbCellera Biologics Inc. (ABCL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
08:01pm, Tuesday, 20'th Feb 2024
Although the revenue and EPS for AbCellera Biologics Inc. (ABCL) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compa
AbCellera to Report Full Year 2023 Financial Results on February 20, 2024
04:05pm, Tuesday, 23'rd Jan 2024
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $ABCL--AbCellera (Nasdaq: ABCL) will announce its full year 2023 financial results on Tuesday, February 20, 2024, and hold an earnings conference call
3 Growth Stocks That Could Go Parabolic in 2024
09:30am, Monday, 15'th Jan 2024
Small- to mid-cap growth stocks largely struggled over the past two years. With the Federal Reserve likely to pivot on interest rates this year, this group may be poised for a trend reversal.
Is AbCellera Biologics (ABCL) Outperforming Other Medical Stocks This Year?
11:19am, Wednesday, 03'rd Jan 2024
Here is how AbCellera Biologics Inc. (ABCL) and Bionano Genomics, Inc. (BNGO) have performed compared to their sector so far this year.
AbCellera to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024
04:05pm, Wednesday, 20'th Dec 2023
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $ABCL--AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the 42nd Annual J.P. Morgan Healthcare Conference on W
AI Meets Biotech: 3 Top Stocks Transforming Medical Science
01:00pm, Saturday, 16'th Dec 2023
One of the biggest stories of the year has been the rise of AI in every industry. This trend will hit biotech stocks no less than any others.
Buy AbCellera Biologics's Revolutionizing AI-Powered Drug Development Platform
11:39pm, Thursday, 07'th Dec 2023
AbCellera Biologics is a biotech company using AI-powered platforms to discover and analyze target-specific antibodies. The company emphasizes partnerships to expedite drug development and has two dru
